Why the study?
What are the rates and reasons for discontinuation of secondary prevention medication after myocardial infarction?
Population
204 patients who had suffered acute myocardial infarction
Design
Cohort
Follow-up
12 months
Authors
Loading...
Emphasizes addressing adverse effects to sustain post-MI adherence; leaves open whether GP-targeted interventions improve long-term persistence.
What are the rates and reasons for discontinuation of secondary prevention medication after myocardial infarction?
Adherence to secondary prevention medication after MI is adequate at 1 year, with most discontinuations driven by GP-initiated changes due to adverse side effects.
Bally et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: